Diseases & Illness |

Stroke News

Timing of Vioxx Damage in Question

RSS News Feeds
Disease from Products
Stroke
 All RSS Feeds

At a glance:

Data recently made public suggests that risk of damage from taking Vioxx may begin earlier, and persist longer, than Merck, the drug maker, claims. 
 
The study in question was done by Merck but not released in its entirety until now. 
 
While Merck continues to insist that risk only begins after 18 months of use, and declines quickly upon stopping the drug, evidence seems to show otherwise, with cardiovascular risk beginning as early as four months into treatment, and persisting for at least a year. 
 
Over 11,000 lawsuits have been filed against Merck. Six have been heard, with Merck winning three and losing three.

New Vioxx data suggest heart attack, stroke risks started within ...

Canada.com - 5/19/2006 5:03 AM

TRENTON, N.J. (AP) - Unpublished data from the Merck & Co. study that led the drugmaker to halt sales of Vioxx appear to show the blockbuster painkiller raised the risk of heart attack and stroke within just a few months - not after at least 18 months' use, as Merck has consistently argued.
 
The company disputed that Thursday, saying it is "not scientifically appropriate" to draw conclusions based on a key graph in a 108-page report on the data.
 
· Read The Full Stroke Article From Canada.com -->

· Read All Stroke News Stories -->

Comments On Stroke News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: